myBiometry, a company focused on remote patient monitoring, has announced it has successfully raised $2.2 million in a recent funding round. This capital infusion marks a significant milestone for the company as it seeks to expand its operations and technological capabilities. The investment underscores growing interest in digital health solutions aimed at improving chronic disease management.
The company operates a platform designed for the remote monitoring and management of patients living with chronic conditions. myBiometry leverages specialized software alongside biomarker data, which is generated from its proprietary sensors. Its initial strategic focus is on providing comprehensive management solutions for individuals with asthma, aiming to offer more proactive and personalized care outside traditional clinical settings.
This newly secured capital will be instrumental in accelerating myBiometry's product development roadmap and scaling its platform. While specific allocation details were not fully disclosed, the company plans to use the funds to enhance its proprietary sensor technology, expand its software features, and grow its team across key departments. The investment is expected to support myBiometry's efforts to broaden its reach within the healthcare market and serve a larger patient population.
The funding round is anticipated to strengthen myBiometry's position in the evolving digital health landscape, particularly in the remote management of chronic respiratory conditions. The company is focused on advancing its mission to improve patient outcomes through accessible, data-driven, and continuous care solutions, aiming for sustained growth and innovation in the coming years.
